NO982556L - Behandling av CNS-virkningene av HIV med VX-478, alene eller i kombinasjon med AZT eller 3TC - Google Patents
Behandling av CNS-virkningene av HIV med VX-478, alene eller i kombinasjon med AZT eller 3TCInfo
- Publication number
- NO982556L NO982556L NO982556A NO982556A NO982556L NO 982556 L NO982556 L NO 982556L NO 982556 A NO982556 A NO 982556A NO 982556 A NO982556 A NO 982556A NO 982556 L NO982556 L NO 982556L
- Authority
- NO
- Norway
- Prior art keywords
- azt
- hiv
- alone
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/567,199 US5646180A (en) | 1995-12-05 | 1995-12-05 | Treatment of the CNS effects of HIV |
PCT/US1996/019447 WO1997020554A1 (en) | 1995-12-05 | 1996-12-05 | Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
Publications (3)
Publication Number | Publication Date |
---|---|
NO982556D0 NO982556D0 (no) | 1998-06-04 |
NO982556L true NO982556L (no) | 1998-06-04 |
NO317837B1 NO317837B1 (no) | 2004-12-20 |
Family
ID=24266147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19982556A NO317837B1 (no) | 1995-12-05 | 1998-06-04 | Anvendelse av forbindelse for fremstilling av et medikament for a inhibere et aspartylproteaseavhengig virus |
Country Status (23)
Country | Link |
---|---|
US (1) | US5646180A (no) |
EP (1) | EP0866696B1 (no) |
JP (1) | JP2000501713A (no) |
KR (1) | KR19990071750A (no) |
CN (1) | CN1203530A (no) |
AP (1) | AP864A (no) |
AT (1) | ATE279922T1 (no) |
AU (1) | AU722850B2 (no) |
BR (1) | BR9611861A (no) |
CA (1) | CA2238471A1 (no) |
CZ (1) | CZ291994B6 (no) |
DE (1) | DE69633680T2 (no) |
ES (1) | ES2231828T3 (no) |
HU (1) | HUP9903673A3 (no) |
NO (1) | NO317837B1 (no) |
NZ (1) | NZ324603A (no) |
OA (1) | OA10691A (no) |
PL (1) | PL187747B1 (no) |
PT (1) | PT866696E (no) |
RU (1) | RU2203658C2 (no) |
UA (1) | UA61902C2 (no) |
WO (1) | WO1997020554A1 (no) |
ZA (1) | ZA9610139B (no) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107499A (en) * | 1988-02-26 | 2000-08-22 | Neuromedica, Inc. | Dopamine analog amide |
US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6486136B1 (en) * | 1996-06-25 | 2002-11-26 | Smithkline Beecham Corporation | Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV |
AP9801419A0 (en) * | 1996-06-25 | 1998-12-31 | Glaxo Group Ltd | Combination comprising VX478, zidovudine, FTC and or 3 |
ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
NZ500868A (en) * | 1997-05-17 | 2001-08-31 | Glaxo Group Ltd | Antiviral combinations comprising 1592U89 and HIV protease inhibitors |
WO1998057648A1 (en) * | 1997-06-16 | 1998-12-23 | Vertex Pharmaceuticals Incorporated | Methods of increasing the bioavailability of stable crystal polymorphs of a compound |
US6576231B2 (en) * | 1997-09-12 | 2003-06-10 | Schering Ag | Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor |
US6197764B1 (en) | 1997-11-26 | 2001-03-06 | Protarga, Inc. | Clozapine compositions and uses thereof |
US5977174A (en) * | 1997-11-26 | 1999-11-02 | Neuromedica, Inc. | Cholinergic compositions and uses thereof |
US5955459A (en) * | 1997-11-26 | 1999-09-21 | Neuromedica, Inc. | Fatty acid-antipsychotic compositions and uses thereof |
US6153653A (en) * | 1997-11-26 | 2000-11-28 | Protarga, Inc. | Choline compositions and uses thereof |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
US6309632B1 (en) * | 1998-04-28 | 2001-10-30 | Immunex Corporation | Methods for treating HIV-infected patients by administering GM-CSF |
US6875773B1 (en) * | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
US20090197827A1 (en) * | 1998-05-29 | 2009-08-06 | Dunn Ben M | Combination Therapy for Treatment of FIV Infection |
US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
DK1328213T3 (da) * | 2000-10-16 | 2005-11-28 | Conor Medsystems Inc | Ekspanderbar medicinsk indretning til afgivelse af et nyttigt middel |
ES2387562T3 (es) * | 2001-03-23 | 2012-09-26 | Luitpold Pharmaceuticals, Inc. | Conjugados alcohol graso-medicamento |
EP1427407A4 (en) | 2001-03-23 | 2005-05-11 | Luitpold Pharm Inc | CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS |
EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
US7871991B2 (en) | 2004-07-27 | 2011-01-18 | Gilead Sciences, Inc. | Phosphonate analogs of HIV inhibitor compounds |
AU2006206399B2 (en) * | 2005-01-20 | 2012-04-05 | University Of Rochester | Compositions and methods relating to mitochondrial hyperpolarization in neurological disease |
CA2634932A1 (en) * | 2005-12-23 | 2007-07-05 | University Of Rochester | Treatment of neuroaids using inhibitors of glycogen synthase kinase (gsk)-3 |
US8642642B2 (en) * | 2006-04-19 | 2014-02-04 | Abbott Laboratories | Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
CN102272134B (zh) | 2008-12-09 | 2013-10-16 | 吉里德科学公司 | Toll样受体调节剂 |
US20110223131A1 (en) | 2010-02-24 | 2011-09-15 | Gilead Sciences, Inc. | Antiviral compounds |
EP3110381B1 (en) | 2014-02-28 | 2020-07-15 | Attends Healthcare Products, Inc. | Absorbent article with multi-layer folded absorbent core |
WO2016001907A1 (en) | 2014-07-02 | 2016-01-07 | Prendergast Patrick T | Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents. |
AU2015287773B2 (en) | 2014-07-11 | 2018-03-29 | Gilead Sciences, Inc. | Modulators of toll-like receptors for the treatment of HIV |
CA2997955A1 (en) | 2015-09-15 | 2017-03-23 | Gilead Sciences, Inc. | Modulators of toll-like receptors for the treatment of hiv |
MX2020012801A (es) | 2018-05-28 | 2021-03-25 | Attends Healthcare Products Inc | Laminado con capa de sequedad para articulos absorbentes. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
AU5748194A (en) * | 1992-12-11 | 1994-07-04 | Vertex Pharmaceuticals Incorporated | Mannitol derivatives and their use as inhibitors of aspartyl protease |
-
1995
- 1995-12-05 US US08/567,199 patent/US5646180A/en not_active Expired - Lifetime
-
1996
- 1996-05-12 UA UA98073527A patent/UA61902C2/uk unknown
- 1996-12-03 ZA ZA9610139A patent/ZA9610139B/xx unknown
- 1996-12-05 BR BR9611861A patent/BR9611861A/pt not_active Application Discontinuation
- 1996-12-05 NZ NZ324603A patent/NZ324603A/xx unknown
- 1996-12-05 WO PCT/US1996/019447 patent/WO1997020554A1/en active IP Right Grant
- 1996-12-05 AP APAP/P/1998/001340A patent/AP864A/en active
- 1996-12-05 JP JP9521449A patent/JP2000501713A/ja active Pending
- 1996-12-05 ES ES96942917T patent/ES2231828T3/es not_active Expired - Lifetime
- 1996-12-05 CN CN96198816A patent/CN1203530A/zh active Pending
- 1996-12-05 DE DE69633680T patent/DE69633680T2/de not_active Expired - Fee Related
- 1996-12-05 AU AU11486/97A patent/AU722850B2/en not_active Ceased
- 1996-12-05 CA CA002238471A patent/CA2238471A1/en not_active Abandoned
- 1996-12-05 CZ CZ19981708A patent/CZ291994B6/cs not_active IP Right Cessation
- 1996-12-05 KR KR1019980704028A patent/KR19990071750A/ko not_active Application Discontinuation
- 1996-12-05 PT PT96942917T patent/PT866696E/pt unknown
- 1996-12-05 EP EP96942917A patent/EP0866696B1/en not_active Expired - Lifetime
- 1996-12-05 RU RU98112594/14A patent/RU2203658C2/ru not_active IP Right Cessation
- 1996-12-05 PL PL96327061A patent/PL187747B1/pl not_active IP Right Cessation
- 1996-12-05 AT AT96942917T patent/ATE279922T1/de not_active IP Right Cessation
- 1996-12-05 HU HU9903673A patent/HUP9903673A3/hu unknown
-
1998
- 1998-05-29 OA OA9800067A patent/OA10691A/en unknown
- 1998-06-04 NO NO19982556A patent/NO317837B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2238471A1 (en) | 1997-06-12 |
AU1148697A (en) | 1997-06-27 |
BR9611861A (pt) | 1999-05-18 |
NO982556D0 (no) | 1998-06-04 |
NO317837B1 (no) | 2004-12-20 |
NZ324603A (en) | 2000-08-25 |
HUP9903673A3 (en) | 2000-08-28 |
ES2231828T3 (es) | 2005-05-16 |
AP864A (en) | 2000-08-11 |
KR19990071750A (ko) | 1999-09-27 |
US5646180A (en) | 1997-07-08 |
EP0866696A1 (en) | 1998-09-30 |
JP2000501713A (ja) | 2000-02-15 |
ATE279922T1 (de) | 2004-11-15 |
CZ170898A3 (cs) | 1998-09-16 |
HUP9903673A2 (hu) | 2000-03-28 |
OA10691A (en) | 2001-05-04 |
WO1997020554A1 (en) | 1997-06-12 |
CZ291994B6 (cs) | 2003-07-16 |
PL187747B1 (pl) | 2004-09-30 |
DE69633680T2 (de) | 2006-02-23 |
DE69633680D1 (de) | 2004-11-25 |
AU722850B2 (en) | 2000-08-10 |
AP9801340A0 (en) | 1998-09-30 |
PT866696E (pt) | 2005-03-31 |
UA61902C2 (en) | 2003-12-15 |
EP0866696B1 (en) | 2004-10-20 |
ZA9610139B (en) | 1997-06-17 |
PL327061A1 (en) | 1998-11-23 |
RU2203658C2 (ru) | 2003-05-10 |
CN1203530A (zh) | 1998-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO982556D0 (no) | Behandling av CNS-virkningene av HIV med VX-478, alene eller i kombinasjon med AZT eller 3TC | |
AU6924796A (en) | 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c | |
NL300195I1 (nl) | Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC. | |
DE9314639U1 (de) | Handlauf, Handgriff o.dgl. | |
DE69306796D1 (de) | Herstellung von feststoffen im nano-bereich | |
DE69505234T2 (de) | Plasmabehandlung in der elektronikapparateherstellung | |
FI970214A0 (fi) | Droloksifeenin käyttö sydänverisuonitautien hoitamiseksi | |
HUP9903249A3 (en) | Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv | |
DK0721522T3 (da) | Iriserende stoffer. | |
DK0808307T3 (da) | Bicykliske isothiourinstofderivater, som kan anvendes ved terapi | |
NO984760D0 (no) | Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon | |
NO881629L (no) | Anvendelse av antigene stoffer ved behandling av lidelseri mage-tarm-kanalen. | |
FI973184A0 (fi) | Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa | |
NO934311D0 (no) | alfa,omega -diarylalkanderivater, deres fremstilling ag anvendelse ved behandling av dirkulasjonssykdommer og psykoser | |
DE68913928D1 (de) | Viskoelastischer Dämpfungskörper und das dazugehörige Herstellungsverfahren. | |
FI902364A0 (fi) | Anordning foer istaondsaettande av underbacken i en hoppbacke. | |
DK0866696T3 (da) | Behandling af HIV ZNS-effekter med VX-478 alene eller i kombination med AZT eller 3TC | |
NL187279C (nl) | Kruisscharnier met hoekbegrenzing van de scharnierdelen. | |
RU97100921A (ru) | Антигипоксический комплекс | |
TH17876EX (th) | ตัวบันได | |
NO903856D0 (no) | Emulgeringsmiddel, invertemulsjoner fremstilt ved hjelp av dette, og anvendelse av invertemulsjonene i borehull. | |
ES1025665Y (es) | Inmovilizador de las extremidades en pacientes que deben permanecer inmoviles. | |
TH17482EX (th) | มือจับก๊อกน้ำ | |
MX9100767A (es) | Mejoras en la fabricacion de hornazas. | |
ES1030366Y (es) | Rebosadero perfeccionado, para bañeras y similares. |